Loading...

WINDLAS Windlas Biotech Ltd Capital Structure Changes Announcement

Wndl

WNDL

Windlas Biotech Ltd

(WINDLAS)

2026 Announcement

Regulatory Compliance Report

Conference Call Recording

Stock option grants

Financial results

Investor Presentation

Final dividend recommendation

Dividend declaration with r...

Earnings Call Invite

Stock Buyback Completion

Buyback Announcement

Board meeting for results

Equity Investment

Appointment of Independent ...

Regulatory Disclosure

Buyback of Shares

Buyback approval

Buyback Tender Offer

Analyst/Investor Meeting

Regulatory compliance

Trading Window Closure

Postal Ballot Despatch

Analyst / Institutional Inv...

Analyst / Institutional Mee...

Earnings Call Transcript

Show Cause Notice

Conference Call Recording

Appointment / Re-appointment

Dissolution of subsidiary

Consolidated results

Investor Presentation

Quarterly financial results

Unaudited results

Conference Call

Board Meeting for Results

Analyst / Institutional Mee...

Regulatory Compliance

Analyst/Institutional meeti...

Trading Window Closure

Analyst / Institutional Inv...

Analyst / Institutional Mee...

Earnings Call Transcript

Conference Call Recording

Financial Results

Investor Presentation

Financial Results H1 FY26

Board Meeting Outcome

Conference Call Scheduled

Board Meeting Notice

Regulatory Compliance

Investor Meetings

Stock Options Granted

Investor Meetings

Investor Meeting

Investor Relations Agency

Investor Meetings

Investor Meetings

Investor Meeting

Stock Units Update

Windlas Plan Update

Q1 FY26 Earnings

Investor Meet Scheduled

Earnings Call Recording

Q1 FY26 Results

Investor Presentation

Conference Call Announcement

Compliance Certificate

Annual Report Dispatch

E-Voting Notice

AGM Announcement

Investor Meeting

Investor Meetings

Q4 FY25 Earnings

Annual Compliance Report

Conference Call Recording

Management Change

Investor Presentation

Q4 FY25 Results

Investor Meet Scheduled

Investor Meetings

Compliance Certificate

Credit Rating Reaffirmed

Investor Meeting

Investor Meet Scheduled

Investor Meeting

Investor Meeting Scheduled

Postal Ballot Notice

Q3 FY25 Earnings

Conference Call Recording

Management Change

Financial Results Q3

Investor Presentation

Conference Call Announcement

GMP Certification Granted

Compliance Certificate

Investor Meeting Notice

Investor Meeting

Q2 FY25 Earnings

Investor Meeting

Investor Meeting

Investor Meeting Notice

Conference Call Recording

Investor Presentation

Strong Financials

Conference Call Scheduled

Investor Meetings

Regulatory Compliance

Investor Meetings Scheduled

Investor Meeting

Investor Meeting

Investor Meeting Scheduled

Investor Meeting

Investor Meeting

Investor Meeting

Investor Meetings Scheduled

Investor Meeting

AGM Notice Dispatch

AGM and E-Voting

Annual General Meeting

Q1 FY25 Earnings

Conference Call Recording

Q1 FY25 Results

Investor Presentation

Conference Call

Analyst Meeting

Investor Meeting

Compliance Certificate Subm...

Postal Ballot Notice

Meeting Intimation

Equity Shares Allotted

Meeting Intimation

Analyst Meeting Intimation

Annual Compliance Report Su...

Audio Recording Upload

Change in Management

Results Presentation

Financial Results Announcement

Conference Call Scheduled

Auditor Conversion

Analyst Meeting

Analyst Meeting

Investor Meeting

Analyst/Investor Meeting

Compliance Certificate Subm...

Investor Meeting

Certificate Submission

Compliance Certificate Subm...

Injectable Facility Commiss...

Analyst Meeting

Conference Call Transcript ...

Analyst/Investor Meet

Annalyst/Investor Meet Sche...

Conference Call Recording

Financial Results

Investor Presentation

Conference Call Scheduled

Analyst/Investor Meet

Certificate Submission

Analyst/Investor Meetings

Analyst/Investor Meet

Analyst Meeting

Schedule Announcement

Conference Call Recording

Financial Results

Results Presentation

Conference Call

Analyst Meet Intimation

Grant of Stock Options

Meeting Schedule

Analyst / Investor Meet

Investor Meetings

Analyst / Investor Meet

Analyst Meetings

Primary Offerings

AGM (Annual General Meeting)

Meeting Announcement

Financial Statements

Financial Statements

Financial Statements

Conference Call

Financial Statements

Analyst Meetings

Analyst Meetings

Analyst / Investor Meetings

Virtual 1x1 Meeting

Earnings Guidance

Conference Call Transcript

Audio Recording Uploaded

Financial Performance

Asset Utilization Statement

Earnings Release

External Links:

Data:

Windlas Biotech approves a ₹47 crore cash buyback of 4.7 lakh shares at ₹1,000 each, funded from the company’s resources, following regulatory norms and a board-approved resolution.

AI Assistant

Windlas Biotech Ltd

2026

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.